Melanotan 1 vs Melanotan 2 2026: Complete Comparison Guide
Disclaimer: betterresultsbook.com contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. betterresultsbook.com makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. betterresultsbook.com makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.
If you have been researching tanning peptides, you have probably encountered Melanotan 1 and Melanotan 2. Both promise sun-kissed skin without extensive UV exposure, but they work quite differently under the hood.
Based on our research, Melanotan 1 (MT1) is the better choice for those seeking pure tanning effects with fewer side effects, while Melanotan 2 (MT2) may appeal to researchers interested in additional effects on sexual function and appetite.
Melanotan 1 and Melanotan 2 are both synthetic peptides derived from alpha-MSH, but they differ significantly in structure and effects. MT1 is a linear 13-amino acid peptide that selectively targets MC1R for tanning, while MT2 is a cyclic 7-amino acid peptide that activates multiple melanocortin receptors, providing tanning plus libido enhancement and appetite suppression with more pronounced side effects.
I have spent considerable time reviewing the scientific literature, clinical trial data, and forum discussions to bring you this comprehensive comparison. Here is what you need to know about these two peptides in 2026.
Quick Comparison: Melanotan 1 vs Melanotan 2
Before we dive into the details, here is a side-by-side comparison of the key differences between these two peptides.
| Feature | Melanotan 1 (MT1) | Melanotan 2 (MT2) |
|---|---|---|
| Structure | Linear peptide (13 amino acids) | Cyclic peptide (7 amino acids) |
| Receptor Target | MC1R only (highly selective) | MC1R, MC3R, MC4R, MC5R (broad) |
| Primary Effects | Tanning, UV protection | Tanning, libido, appetite suppression |
| FDA Status | Approved as Scenesse for EPP | Not FDA-approved |
| Potency | Lower per milligram | Higher per milligram |
| Tanning Speed | Gradual, more natural | Faster, more aggressive |
| Nausea Rate | 19% of users | 41% of users |
| Sexual Effects | Minimal to none | Significant enhancement |
| Price Range | $40-60 per 10mg vial | $35-50 per 10mg vial |
The bottom line is that MT1 offers targeted tanning with a better safety profile, while MT2 provides stronger effects across multiple systems but with more side effects.
What Is Melanotan 1?
Melanotan 1 is a linear synthetic peptide that mimics alpha-melanocyte-stimulating hormone (alpha-MSH), the natural hormone responsible for triggering melanin production in your skin.
Melanotan 1: A 13-amino acid linear peptide analog of alpha-MSH, also known as afamelanotide or Scenesse, that selectively activates MC1R receptors to stimulate eumelanin production in the skin.
What sets MT1 apart is its remarkable selectivity. It binds primarily to the MC1R receptor, which is found predominantly in melanocytes, the cells responsible for producing melanin.
This targeted approach means MT1 produces its tanning effect with minimal activation of other melanocortin receptors that affect appetite, sexual function, and other physiological processes.
Molecular Structure
MT1 has a molecular weight of 1646.8 g/mol and consists of 13 amino acids in a linear chain. Its sequence is Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2.
The linear structure is more similar to natural alpha-MSH, which may contribute to its better safety profile compared to MT2.
FDA Approval Status
Here is something significant: Melanotan 1 is the only one of these peptides with FDA approval.
Under the brand name Scenesse, afamelanotide (MT1) received FDA approval for treating erythropoietic protoporphyria (EPP), a rare genetic condition that causes extreme sun sensitivity. Clinical trials involving over 900 patients demonstrated its safety and efficacy.
MT1 is also being investigated for other photodermatoses including polymorphic light eruption, vitiligo, and xeroderma pigmentosa.
How MT1 Works?
When MT1 binds to MC1R receptors on melanocytes, it triggers a signaling cascade that increases eumelanin production. Eumelanin is the brown-black pigment that provides both visible tanning and natural UV protection.
Clinical studies suggest MT1 may boost pigmentation by up to 75% and reduce sunburn risk by 47% when combined with UV exposure. This photoprotective effect is what makes it valuable for patients with sun sensitivity conditions.
What Is Melanotan 2?
Melanotan 2 is a cyclic synthetic peptide that was developed as a more potent variant of MT1. While it also triggers tanning, its effects extend far beyond skin pigmentation.
Melanotan 2: A 7-amino acid cyclic peptide with a lactam ring structure that activates multiple melanocortin receptors (MC1R through MC5R), producing effects on skin pigmentation, sexual function, appetite, and body weight.
The key difference is receptor selectivity. MT2 is what researchers call a non-selective melanocortin receptor agonist, meaning it activates several receptor subtypes throughout the body.
Molecular Structure
MT2 has a molecular weight of 1024.2 g/mol, making it significantly smaller than MT1. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2.
The cyclic structure with its lactam ring makes MT2 more resistant to enzymatic breakdown, contributing to its longer half-life and higher potency per milligram compared to the linear MT1.
Multi-Receptor Activity
MT2 activates several melanocortin receptors, each producing different effects:
- MC1R: Skin pigmentation and tanning
- MC3R: Energy regulation and metabolism
- MC4R: Sexual function, appetite suppression, and body weight
- MC5R: Sebaceous gland function and exocrine secretions
This broad receptor profile explains why MT2 users may experience effects on libido, appetite, and weight alongside tanning, something that does not happen with MT1.
The PT-141 Connection
Bremelanotide (PT-141), which is FDA-approved for treating hypoactive sexual desire disorder in women, was actually derived from Melanotan 2 research. This derivative isolates the sexual function effects by removing the tanning properties.
The FDA approval of PT-141 demonstrates that the sexual function effects of MT2 are clinically significant, though MT2 itself remains unapproved.
Key Differences Between Melanotan 1 and 2
Now that we understand each peptide individually, let us examine the critical differences that should inform your research decisions.
1. Structural Differences
The fundamental difference is molecular structure. MT1 is a linear 13-amino acid chain, while MT2 is a cyclic 7-amino acid ring.
This structural difference affects everything from potency to side effect profile. The cyclic structure of MT2 makes it more resistant to breakdown, meaning it stays active longer in the body and requires lower doses for similar tanning effects.
2. Receptor Selectivity
MT1 is highly selective for the MC1R receptor. In contrast, MT2 activates MC1R, MC3R, MC4R, and MC5R with significant affinity.
This selectivity difference is crucial. MC1R controls pigmentation, which is why both peptides tan. But MC4R activation by MT2 triggers sexual arousal and appetite suppression, effects completely absent with MT1.
3. Potency and Dosing
Research suggests MT2 is more potent per milligram for tanning effects. Studies indicate MT2 produces noticeable skin darkening at lower cumulative doses than MT1.
Typical research dosages differ accordingly:
- MT1: 1-2mg daily for loading periods
- MT2: 0.5mg daily for tanning; 1-2mg for other effects
4. Regulatory Status
This is a significant differentiator. MT1 (as Scenesse/afamelanotide) has FDA approval for erythropoietic protoporphyria, backed by clinical trials with over 900 patients.
MT2 has no FDA approval for any indication. However, its derivative PT-141 (Bremelanotide) is FDA-approved for female sexual dysfunction, validating some of MT2’s mechanisms.
5. Effect Profile
| Effect | Melanotan 1 | Melanotan 2 |
|---|---|---|
| Tanning | Yes (gradual) | Yes (faster/stronger) |
| UV Protection | Yes (primary benefit) | Yes |
| Libido Enhancement | No | Yes (significant) |
| Erectile Function | No | Yes |
| Appetite Suppression | No | Yes |
| Weight Loss Potential | No | Yes (research stage) |
Benefits Comparison: MT1 vs MT2
Both peptides offer distinct advantages depending on your research goals. Let us break down the benefits in each category.
Tanning and Skin Pigmentation
Both MT1 and MT2 effectively stimulate melanin production, but they do so differently.
Melanotan 1: Provides gradual, more natural-looking pigmentation. Users report the tan develops evenly and maintains a realistic appearance. According to forum discussions, people who switched from MT2 to MT1 appreciated the slower, more controlled tanning effect.
Melanotan 2: Delivers faster, more aggressive tanning. Noticeable skin darkening may occur within 3-7 days of starting a loading protocol. However, some users report uneven pigmentation or a tan that develops too quickly to look natural.
Photoprotection and UV Benefits
MT1 has the edge here, with clinical evidence supporting its photoprotective properties. Studies suggest it may reduce sunburn risk by approximately 47% and increase pain-free sun exposure time in patients with EPP.
MT2 also provides some UV protection through increased melanin, but it lacks the extensive clinical data supporting MT1’s photoprotective claims.
Sexual Function Effects
This is where MT2 stands alone. Its activation of MC4R receptors produces significant effects on sexual function in both males and females.
Research indicates MT2 may enhance libido, improve erectile function, and increase sexual arousal. These effects were considered significant enough that a derivative (PT-141/Bremelanotide) was developed specifically for sexual dysfunction treatment.
MT1 has minimal to no effect on sexual function due to its selective MC1R binding.
Appetite and Weight Effects
MT2’s activation of MC3R and MC4R receptors affects appetite and metabolism. Many users report appetite suppression as a notable effect, and some view this as a benefit for weight management.
Research into melanocortin peptides for obesity treatment is ongoing, with MT2 showing potential in preclinical studies. However, this remains investigational.
MT1 does not affect appetite or body weight due to its receptor selectivity.
Research Note: The multi-benefit profile of MT2 may seem attractive, but it comes with trade-offs in predictability and side effects. Users seeking only tanning benefits may find MT1’s targeted approach preferable.
Side Effects Comparison
Understanding the side effect profiles is essential for informed decision-making. The differences here are substantial.
Melanotan 1 Side Effects
Clinical trial data from Scenesse provides reliable side effect information for MT1:
- Nausea: 19% of patients
- Fatigue: 6% of patients
- Skin darkening: 4% (beyond desired effect)
- Dizziness: 4% of patients
- Mole development: 4% of patients
Overall, MT1 has a relatively mild side effect profile, with nausea being the most common complaint. The selective MC1R binding limits systemic effects.
Melanotan 2 Side Effects
MT2’s broader receptor activity produces more pronounced and varied side effects:
- Nausea: 41% of users (more than twice MT1)
- Facial flushing: Common, especially with initial doses
- Yawning/stretching: 56% of users
- Appetite changes: Common (may be desired or unwanted)
- Spontaneous erections: Common in males
- Priapism: Rare but serious (prolonged erection requiring medical attention)
- Mole changes: Darkening of existing moles
Important Safety Note: Both peptides may cause changes to moles and freckles. Regular monitoring by a dermatologist is advisable for anyone using these peptides. There are theoretical concerns about melanoma risk with prolonged use, though clinical data is limited.
Managing Common Side Effects
Based on user experiences shared in forums, here are strategies that may help manage common side effects:
- For nausea: Taking doses before bedtime allows users to sleep through the worst effects
- For facial flushing: Some users report antihistamines may help reduce this reaction
- For injection site reactions: Proper rotation of injection sites and sterile technique
Which One Should You Choose?
The right choice depends entirely on your research goals and risk tolerance. Here is a decision framework based on our analysis.
Choose Melanotan 1 If:
- You want tanning effects only, without systemic effects
- You prefer a gradual, more natural-looking tan
- You are researching photoprotection or UV-related conditions
- You want the option with FDA approval and clinical trial backing
- You prefer a milder side effect profile
- You do not want effects on sexual function or appetite
Choose Melanotan 2 If:
- You are interested in multi-benefit effects (tanning + other effects)
- You want faster, more pronounced tanning results
- You are researching sexual function or appetite mechanisms
- You are comfortable managing more pronounced side effects
- You prefer lower-dose protocols due to higher potency
Avoid Both If:
- You have a history of skin cancer or atypical moles
- You are pregnant or breastfeeding
- You are under 18 years of age
- You have cardiovascular conditions (particularly relevant for MT2)
Forum Insight: Users who initially chose MT2 for faster results sometimes switch to MT1 when they find the side effects too pronounced or the tanning too rapid and uneven. Starting with MT1 may be a more cautious approach.
Dosage and Administration Overview
The following information is provided for educational purposes regarding research protocols. These are not recommendations for human use.
Melanotan 1 Research Dosing
Research protocols typically involve 1-2mg administered daily during a loading phase of approximately 10 days, followed by maintenance dosing. MT1 is administered via subcutaneous injection or as an implant (in the approved Scenesse formulation).
Melanotan 2 Research Dosing
Due to higher potency, MT2 research typically uses lower doses:
- For tanning research: 0.5mg daily for up to 14 days
- For sexual function research: 1-2mg up to 4 times monthly (with 48+ hours between doses)
MT2 is administered via subcutaneous injection or nasal spray formulations.
Reconstitution and Storage
Both peptides require reconstitution with bacteriostatic water before use. Once reconstituted, they should be refrigerated and typically used within a few weeks. Proper sterile technique and insulin syringes are standard for subcutaneous administration.
Frequently Asked Questions
Does Melanotan 1 make you tan?
Yes, Melanotan 1 stimulates melanocytes to produce eumelanin, resulting in skin darkening. Clinical studies suggest MT1 may boost pigmentation by up to 75% when combined with UV exposure. It works by selectively activating MC1R receptors in the skin, providing a gradual, natural-looking tan.
What is the difference between MT1 and MT2?
MT1 is a linear peptide selective for MC1R (tanning only), while MT2 is a cyclic peptide that activates multiple receptors affecting tanning, libido, and appetite. MT1 has fewer side effects and FDA approval as Scenesse. MT2 is more potent but has broader systemic effects including nausea (41% vs 19%), sexual arousal, and appetite suppression.
How long does Melanotan 2 take to tan?
Melanotan 2 may produce noticeable skin darkening within 3-7 days when combined with minimal UV exposure. The effect develops faster than MT1 due to MT2’s higher potency and broader receptor activation. Most users report visible tanning effects during the loading phase.
Does Melanotan 2 fade?
Yes, Melanotan 2 tanning effects fade when you stop using the peptide. Melanin levels will gradually decrease and the tan will diminish over weeks to months. Maintenance doses are typically used to preserve pigmentation. The fade rate depends on individual metabolism and sun exposure.
Is Melanotan 1 FDA approved?
Yes, Melanotan 1 is FDA-approved under the brand name Scenesse (afamelanotide) specifically for treating erythropoietic protoporphyria (EPP), a rare genetic condition causing extreme sun sensitivity. It is the only melanotan peptide with FDA approval. Clinical trials involved over 900 patients demonstrating its safety and efficacy.
Does Melanotan 2 affect libido?
Yes, Melanotan 2 significantly affects libido in both males and females. This occurs through activation of MC4R receptors, which regulate sexual arousal. The effect was significant enough that a derivative (PT-141/Bremelanotide) was developed and FDA-approved specifically for treating hypoactive sexual desire disorder. MT1 does not have this effect.
The Bottom Line
Melanotan 1 and Melanotan 2 serve different purposes despite sharing a common origin. MT1 is the targeted choice for pure tanning research with FDA backing and fewer side effects. MT2 offers more potent tanning with additional effects on sexual function and appetite, but at the cost of more pronounced side effects.
For researchers focused solely on skin pigmentation, MT1’s selective MC1R activity and clinical validation make it the more conservative option. For those interested in the broader melanocortin system effects, MT2 provides a multi-target approach.
Whatever your research direction, understanding these fundamental differences helps you make an informed decision aligned with your specific goals.
FDA Disclaimer: Melanotan 2 and research-grade Melanotan 1 are not FDA-approved for human use. Only Scenesse (afamelanotide) is FDA-approved, specifically for erythropoietic protoporphyria. Research peptides are intended for laboratory research only.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before considering any peptide or medication. The information provided here is based on research literature and should not be used for self-diagnosis or treatment.
